Titan PharmaceuticalsTTNP
13F holders, Q1 2026 (March 31)6holders +2
2new positions
0sold out
$1.38avg. 13F price*
At the end of Q1 2026, 6 institutions reported holding Titan Pharmaceuticals Inc. (TTNP) in their 13F filings, up 2 from Q4 2025. 2 opened new positions and 0 sold out. The largest holders were CoreCap Advisors, LLC ($123), Global Wealth Strategies & Associates ($3) and Caldwell Sutter Capital, Inc. ($1).
- Company
- Titan Pharmaceuticals Inc.
- Filed as
- BLACK TITAN CORP ORD SHS (Q1 2026)
- CUSIP
- 888314705
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $2 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 2 shares bought, net +2 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| CoreCap Advisors, LLC | 0.00% | No change | 88 | $123 |
| Global Wealth Strategies & Associates | 0.00% | No change | 2 | $3 |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 1 | $1 |
| St Germain D J Co. Inc. | 0.00% | No change | 1 | $1 |
| Bogart Wealth, LLC | 0.00% | New | 1 | $1 |
| Farther Finance Advisors, LLC | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is TTNP's weight in each manager's 13F, not the share of Titan Pharmaceuticals Inc. the manager owns.